Risk reduction strategies for women with an elevated risk of breast cancer include surgery, namely bilateral mastectomy and bilateral pre-menopausal salpingo-oophorectomy, and medication such as selective estrogen receptor modulators (SERMs) (Rebbeck et al. 2009; Rebbeck et al. 2004). The gene discussed is ESR1; the disease is breast carcinoma.